Additionally, the CSF levels of Aβ1-38 were significantly lower in the atypical AD compared to the typical AD group (p = 0.002), although the results of other CSF biomarkers and the prevalence of APOE ε4 allele did not differ significantly between the typical AD and atypical AD groups (Table 1). This evidence concerns the gene APOE and Alzheimer disease.